Person

Bernard J. Zovighian

CEO · Director, Edwards Lifesciences

Current S&P 500 boards
1
Current roles
1
Open-market buys
$50K
Open-market sales
$14.2M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Jul 27, 2026EWSale2,921$83.93$245K
Jun 17, 2026EWSale523$87.92$46K
May 12, 2026EWSale35,506$77.92$2.8M
May 12, 2026EWSale845$78.40$66K
Feb 12, 2026EWSale19,898$76.61$1.5M
Feb 12, 2026EWSale2,532$77.13$195K
Dec 10, 2025EWSale3,863$83.45$322K
Dec 8, 2025EWSale21,487$85.21$1.8M
Jun 3, 2025EWSale967$77.32$75K
May 30, 2025EWSale16,099$77.21$1.2M
May 5, 2025EWSale5,980$74.91$448K
Mar 10, 2025EWSale6,164$69.51$428K
May 30, 2024EWSale8,617$87.68$756K
May 6, 2024EWBuy580$85.74$50K
Aug 5, 2022EWSale4,811$103.66$499K
Jun 14, 2022EWSale4,809$87.75$422K
May 31, 2022EWSale9,000$100.83$907K
May 24, 2022EWSale4,809$95.52$459K
Apr 27, 2017EWSale18,050$109.21$2.0M

SEC reporting-owner ID (CIK) 1665141 · all filings on EDGAR